Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,007 public trials 2,555 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
Locations
  • Kaiser Permanente-Division of Research Pleasanton, California, United States
  • Keefe Memorial Hospital Cheyenne Wells, Colorado, United States
  • Kaiser Permanente-Franklin Denver, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 44 locations
View Trial Details
Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

NCT07011719

Conditions
Advanced Clear Cell Renal Cell Carcinoma, Clear-cell metastatic renal cell carcinoma, Female Urogenital Diseases, +11 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Goodyear, Arizona, United States
  • Research Site Phoenix, Arizona, United States
  • Research Site Duarte, California, United States
View all 176 locations
View Trial Details
Recruiting

Serial MRI Scans During Radiation Therapy

NCT04188535

Conditions
Astrocytoma, Digestive System Diseases, Digestive System Neoplasms, +38 more
Locations
  • Brigham and Women Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer

NCT07192614

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Research Site Orlando, Florida, United States
  • Research Site Tampa, Florida, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Grand Rapids, Michigan, United States
View all 26 locations
View Trial Details
Recruiting

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

NCT07200830

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
View all 129 locations
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

NCT07216105

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +48 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia, Pennsylvania, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer

NCT04981509

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +21 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View all 13 locations
View Trial Details

Related conditions